A Combination of Niraparib Plus Anlotinib in Patients with Platinum-Resistant Ovarian Clear Cell Carcinoma: Results of a Single-Arm Phase II Study (CC-ANNIE Study).
JOURNAL OF CLINICAL ONCOLOGY（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined